Rabishield

The rabies virus is transmitted through the saliva of infected animals. People usually become infected with the virus if they get bitten by an infected animal. However, any contact with the saliva of an infected animal (alive or dead) can potentially lead to infection if the person has an opening in the skin or the saliva gets into their eyes, nose, or mouth.

Rabies is a 100% preventable disease. Proper wound management and simultaneous administration of Rabishield 100IU Injection combined with anti-rabies vaccine (ARV) is almost invariably effective in preventing rabies, even after high-risk exposure.

Rabishield 100IU Injection is not required for patients who have previously received a complete vaccination series of rabies.

Whether Rabishield 100IU Injection is painful or not depends on your pain tolerance. During your initial treatment, a healthcare professional will put Rabishield 100IU Injection in the area where you were bitten which can be painful. Therefore, you may need a relatively greater amount of Rabishield 100IU Injection may be required to be placed in and around the wound site to ease out your pain and treat infection.

Post exposure prophylaxis (PEP) consists of a dose of human rabies immune globulin (HRIG) and rabies vaccine. It is given on the day of the rabies exposure and after that a dose of vaccine is given again on days 3, 7, and 14. For people who have never been vaccinated against rabies previously, post exposure prophylaxis (PEP) should always include administration of both HRIG and rabies vaccine. The combination of HRIG and vaccine is recommended for both bite and non-bite exposures, regardless of the interval between exposure and initiation of treatment.

Yes, Rabishield 100IU Injection can be taken by a pregnant woman. Cases of any fetal abnormalities in pregnant women have not been reported with the use of Rabishield 100IU Injection. The doctor may even suggest routine pre-exposure vaccination against rabies if the risk of exposure is high.